Virtual Reality on Anxiety, Stress, Pain and Patient's Satisfaction Among Patients Undergoing Colonoscopy
VR/RCT
Effect of Virtual Reality on Anxiety, Stress, Pain and Patient's Satisfaction Among Palestinian Patients Undergoing Colonoscopy: A Randomized Controlled Trial
1 other identifier
interventional
150
1 country
1
Brief Summary
The goal of this randomized controlled trial was to investigate the effect of Virtual Reality (VR) on anxiety, stress, pain, and patient satisfaction among Palestinian patients undergoing colonoscopy. The study aimed to determine the efficacy of VR as a non-pharmacological intervention to improve the patient experience during the procedure. The main research hypotheses are: H01: There will be no significant difference in anxiety levels between patients who receive immersive VR during colonoscopy and those who receive standard care. H02: There will be no significant difference in perceived stress levels between patients who receive immersive VR during colonoscopy and those who receive standard care. H03: There will be no significant difference in pain levels between patients who receive immersive VR during colonoscopy and those who receive standard care. H04: There will be no significant difference in satisfaction levels between patients who receive immersive VR during colonoscopy and those who receive standard care. Participants will: Receive either a VR intervention or standard care during their colonoscopy. Wear a VR headset for 15-30 minutes, immersing themselves in a natural environment with relaxing music and nature sounds. Complete assessments of anxiety, stress, pain, and satisfaction before and after the procedure using validated questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable anxiety
Started Sep 2024
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2025
CompletedFirst Submitted
Initial submission to the registry
August 21, 2025
CompletedFirst Posted
Study publicly available on registry
August 28, 2025
CompletedAugust 28, 2025
August 1, 2025
4 months
August 21, 2025
August 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
State-Trait Anxiety Inventory (STAI)
The STAI score ranges between 20-80, the higher score indicating greater anxiety. It is classified as "no or low anxiety" (20-37), "moderate anxiety" (38-44), and "high anxiety" (45-80)
before colonoscopy and then 60 minutes post-procedure
Perceived Stress Scale (PSS-10)
The PSS-10 score can range from 0 to 40 with higher scores indicating higher perceived stress. It is classified as "no or low anxiety" (0-13), "moderate anxiety" (14-26), and "high anxiety" (27-40).
before colonoscopy and then 60 minutes post-procedure
Study Arms (2)
VR group
EXPERIMENTALThe VR intervention utilized a head-mounted VR headset with built-in headphones. Patients selected VR environments from a predefined list of natural scenes, including tropical beach, diving, forest, and snowy landscape, each accompanied by relaxing music and nature sounds. The Guided Meditation VR application from Cubicle Ninjas (https://guidedmeditationvr.com/) provided 360-degree immersive nature environments with standardized calming background audio. VR was applied during the colonoscopy procedure, with sessions lasting 15 to 30 minutes and discontinued if the patient experienced nausea, dizziness, or requested removal.
control group
NO INTERVENTIONParticipants in the control group received only standard care according to the hospital's protocol during the colonoscopy procedure.
Interventions
The VR intervention used a head-mounted VR headset with built-in headphones. Patients selected VR environments from a predefined list of four nature scenes (tropical beach, diving, forest, and snowy landscape) with relaxing music and nature sounds. Guided Meditation VR from Cubicle Ninjas (https://guidedmeditationvr.com/) featured 360-degree immersive nature environments with standardized calming background audio. VR was applied during the colonoscopy procedure, with sessions lasting 15 to 30 minutes and discontinued if the patient reported nausea, dizziness, or requested removal.
Eligibility Criteria
You may qualify if:
- Patients scheduled for elective colonoscopy
- Patients older than 18 years
- Patients with no history of previous colonoscopy procedures
- Patients experiencing moderate to severe anxiety and stress
You may not qualify if:
- Patients who have a history of psychiatric disorders, epilepsy, hypertension, or chronic pain.
- Patients who are mute and could not read, or write, patients with visual, hearing, or cognitive impairment.
- Patients who implanted hearing aids or cardiac pacemakers.
- Patients who were given any anxiolytic, sedative, or hypnotic drugs before or during procedure.
- Patients who were exposed to complications during the operation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Rafidia Surgical Governmental Hospital
Nablus, West Bank, Palestinian Territories
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 21, 2025
First Posted
August 28, 2025
Study Start
September 10, 2024
Primary Completion
December 30, 2024
Study Completion
February 10, 2025
Last Updated
August 28, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) cannot be shared due to ethical concerns about participant privacy and the inappropriate use of data. Also, compliance with journal publication policies.